Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 28/13/28 |
C. Payne
DFI | Director of Finance/CFO | 61 | 27/22/27 |
Chief Tech/Sci/R&D Officer | - | 01/19/01 | |
Rafael Bejar
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/20/01 |
Investor Relations Contact | - | - | |
Marc Wiles
LAW | General Counsel | - | - |
Brooks Ensign
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 19/07/19 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 13/22/13 |
Mark Vincent
BRD | Director/Board Member | 71 | 19/07/19 |
Director/Board Member | 74 | 15/14/15 | |
William Rice
CEO | Chief Executive Officer | 65 | 28/13/28 |
Warren Whitehead
BRD | Director/Board Member | 71 | 07/11/07 |
Carol Ashe
BRD | Director/Board Member | 66 | 15/18/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,109,393 | 15,009,253 ( 82.88 %) | 0 | 82.88 % |
Company contact information
Aptose Biosciences, Inc.
251 Consumers Road Suite 1105
M2J 4R3, Toronto
+647 479 9828
http://www.aptose.com![address Aptose Biosciences](https://cdn.zonebourse.com/static/address/18469147.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 3.94TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
+10.74% | 2.59TCr | |
-13.50% | 2.6TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr | |
-12.61% | 1.06TCr |